FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1566131907> ?p ?o ?g. }

• W1566131907 endingPage "99" @default.
• W1566131907 startingPage "87" @default.
• W1566131907 abstract "Background Effective anthracycline-free combinations need to be evaluated in metastatic breast cancer (MBC), due to the increased number of patients treated with anthracycline-based adjuvant chemotherapy. Patients and methods Patients with MBC were randomized to paclitaxel and carboplatin (PCb) every 3 weeks or docetaxel and gemcitabine (GDoc) every 3 weeks or weekly paclitaxel (Pw). Trastuzumab was given to patients with HER-2 over-expressing tumors. The primary endpoint of the study was survival. Quality of life (QoL) and cost were assessed. Results Totally, 416 eligible patients entered the study. Median survival times were 29.9 months for PCb, 26.9 for GDoc and 41.0 for Pw (P = 0.037). According to multivariate analysis, adjuvant chemotherapy, >1 metastatic sites, lack of maintenance hormonal therapy, and worse performance status (PS) were significant adverse prognostic factors for survival, while Pw when compared to GDoc improved survival (P = 0.03), as well as when compared to PCb in the subgroup of patients with PS = 1 (P = 0.01, treatment by PS interaction P = 0.03). No significant differences in terms of time to progression were found. Severe myelotoxicity and mucositis were more frequent with GDoc, while severe neuropathy with PCb and Pw. QoL changes did not differ significantly between treatment groups, while cost analysis favored Pw. Conclusions Pw appears to be the most preferable choice among the 3 anthracycline-free taxanes-based regimens tested in the present study." @default.
• W1566131907 created "2016-06-24" @default.
• W1566131907 creator A5005730021 @default.
• W1566131907 creator A5010017616 @default.
• W1566131907 creator A5012112204 @default.
• W1566131907 creator A5018787724 @default.
• W1566131907 creator A5026269698 @default.
• W1566131907 creator A5031587640 @default.
• W1566131907 creator A5033573338 @default.
• W1566131907 creator A5036525497 @default.
• W1566131907 creator A5039349296 @default.
• W1566131907 creator A5041575636 @default.
• W1566131907 creator A5047656028 @default.
• W1566131907 creator A5048322584 @default.
• W1566131907 creator A5057164541 @default.
• W1566131907 creator A5060690257 @default.
• W1566131907 creator A5060795077 @default.
• W1566131907 creator A5072838496 @default.
• W1566131907 creator A5084058671 @default.
• W1566131907 creator A5085173975 @default.
• W1566131907 creator A5089476301 @default.
• W1566131907 creator A5090633646 @default.
• W1566131907 date "2008-05-16" @default.
• W1566131907 modified "2023-09-26" @default.
• W1566131907 title "A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer" @default.
• W1566131907 cites W1907604566 @default.
• W1566131907 cites W1946759281 @default.
• W1566131907 cites W1946819517 @default.
• W1566131907 cites W1987530510 @default.
• W1566131907 cites W2013981808 @default.
• W1566131907 cites W2017112931 @default.
• W1566131907 cites W2043103956 @default.
• W1566131907 cites W2076668534 @default.
• W1566131907 cites W2082246284 @default.
• W1566131907 cites W2092087181 @default.
• W1566131907 cites W2095551096 @default.
• W1566131907 cites W2096499163 @default.
• W1566131907 cites W2101713088 @default.
• W1566131907 cites W2106427904 @default.
• W1566131907 cites W2116996913 @default.
• W1566131907 cites W2126942676 @default.
• W1566131907 cites W2136791645 @default.
• W1566131907 cites W2143354760 @default.
• W1566131907 cites W2154590531 @default.
• W1566131907 cites W2154795762 @default.
• W1566131907 cites W2155808778 @default.
• W1566131907 cites W2159421244 @default.
• W1566131907 cites W2165824128 @default.
• W1566131907 cites W4248735138 @default.
• W1566131907 doi "https://doi.org/10.1007/s10549-008-0047-9" @default.
• W1566131907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18483853" @default.
• W1566131907 hasPublicationYear "2008" @default.
• W1566131907 type Work @default.
• W1566131907 sameAs 1566131907 @default.
• W1566131907 citedByCount "74" @default.
• W1566131907 countsByYear W15661319072012 @default.
• W1566131907 countsByYear W15661319072013 @default.
• W1566131907 countsByYear W15661319072014 @default.
• W1566131907 countsByYear W15661319072015 @default.
• W1566131907 countsByYear W15661319072016 @default.
• W1566131907 countsByYear W15661319072017 @default.
• W1566131907 countsByYear W15661319072018 @default.
• W1566131907 countsByYear W15661319072020 @default.
• W1566131907 countsByYear W15661319072021 @default.
• W1566131907 countsByYear W15661319072022 @default.
• W1566131907 countsByYear W15661319072023 @default.
• W1566131907 crossrefType "journal-article" @default.
• W1566131907 hasAuthorship W1566131907A5005730021 @default.
• W1566131907 hasAuthorship W1566131907A5010017616 @default.
• W1566131907 hasAuthorship W1566131907A5012112204 @default.
• W1566131907 hasAuthorship W1566131907A5018787724 @default.
• W1566131907 hasAuthorship W1566131907A5026269698 @default.
• W1566131907 hasAuthorship W1566131907A5031587640 @default.
• W1566131907 hasAuthorship W1566131907A5033573338 @default.
• W1566131907 hasAuthorship W1566131907A5036525497 @default.
• W1566131907 hasAuthorship W1566131907A5039349296 @default.
• W1566131907 hasAuthorship W1566131907A5041575636 @default.
• W1566131907 hasAuthorship W1566131907A5047656028 @default.
• W1566131907 hasAuthorship W1566131907A5048322584 @default.
• W1566131907 hasAuthorship W1566131907A5057164541 @default.
• W1566131907 hasAuthorship W1566131907A5060690257 @default.
• W1566131907 hasAuthorship W1566131907A5060795077 @default.
• W1566131907 hasAuthorship W1566131907A5072838496 @default.
• W1566131907 hasAuthorship W1566131907A5084058671 @default.
• W1566131907 hasAuthorship W1566131907A5085173975 @default.
• W1566131907 hasAuthorship W1566131907A5089476301 @default.
• W1566131907 hasAuthorship W1566131907A5090633646 @default.
• W1566131907 hasBestOaLocation W15661319072 @default.
• W1566131907 hasConcept C121608353 @default.
• W1566131907 hasConcept C126322002 @default.
• W1566131907 hasConcept C143998085 @default.
• W1566131907 hasConcept C2775930923 @default.
• W1566131907 hasConcept C2776694085 @default.
• W1566131907 hasConcept C2776802502 @default.
• W1566131907 hasConcept C2777292972 @default.
• W1566131907 hasConcept C2777511904 @default.
• W1566131907 hasConcept C2778239845 @default.
• W1566131907 hasConcept C2778496288 @default.

• next